HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Youjin Kim Selected Research

DA-1241

1/2022DA-1241, a Novel GPR119 Agonist, Improves Hyperglycaemia by Inhibiting Hepatic Gluconeogenesis and Enhancing Insulin Secretion in Diabetic Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Youjin Kim Research Topics

Disease

16Neoplasms (Cancer)
04/2024 - 06/2016
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 10/2018
5Obesity
01/2017 - 11/2011
4Stomach Neoplasms (Stomach Cancer)
10/2019 - 12/2017
4Osteoporosis
01/2017 - 07/2013
3Inflammation (Inflammations)
12/2023 - 07/2013
2Hematologic Neoplasms (Hematological Malignancy)
04/2024 - 09/2023
2Leukemia
04/2024 - 04/2023
2Adenoid Cystic Carcinoma (Cylindroma)
04/2024 - 01/2017
2Breast Neoplasms (Breast Cancer)
10/2023 - 02/2019
2Chronic Disease (Chronic Diseases)
01/2023 - 06/2014
2Overweight
03/2022 - 05/2019
2Weight Loss (Weight Reduction)
03/2022 - 05/2019
2Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 10/2020
2Anemia
01/2020 - 01/2018
2Carcinoma (Carcinomatosis)
10/2019 - 01/2018
2Neoplasm Metastasis (Metastasis)
10/2019 - 10/2018
2Sarcoma (Soft Tissue Sarcoma)
01/2018 - 01/2018
2Sarcopenia
01/2017 - 01/2016
1Multiple Myeloma
04/2024
1Lymphoma (Lymphomas)
04/2024
1COVID-19
04/2024
1Large Granular Lymphocytic Leukemia
04/2023
1Alzheimer Disease (Alzheimer's Disease)
01/2023
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2023
1End Stage Liver Disease
01/2023
1Graft vs Host Disease (Graft-Versus-Host Disease)
09/2022
1Fatty Liver
01/2022
1Body Weight (Weight, Body)
01/2022
1Insulinoma
01/2022
1Infections
06/2021
1Hypertension (High Blood Pressure)
08/2020
1Type 2 Diabetes Mellitus (MODY)
12/2019
1Fatigue
10/2019
1Pruritus (Itching)
10/2019
1Colorectal Neoplasms (Colorectal Cancer)
07/2019
1Constipation
05/2019
1Alopecia (Baldness)
05/2019
1Prostatic Neoplasms (Prostate Cancer)
05/2019

Drug/Important Bio-Agent (IBA)

4Tyrosine Kinase InhibitorsIBA
04/2024 - 10/2018
4ErbB Receptors (EGF Receptor)IBA
04/2019 - 10/2018
3Biomarkers (Surrogate Marker)IBA
09/2022 - 10/2019
3Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2017
3Gefitinib (Iressa)FDA Link
04/2019 - 10/2018
2MineralsIBA
12/2023 - 01/2016
2B7-H1 AntigenIBA
01/2023 - 10/2019
2CalciumIBA
03/2022 - 05/2019
2Triglycerides (Triacylglycerol)IBA
01/2022 - 08/2020
2Immune Checkpoint InhibitorsIBA
01/2021 - 01/2019
2LipidsIBA
08/2020 - 01/2017
2Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2019 - 01/2019
2AfatinibIBA
04/2019 - 01/2019
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
06/2014 - 07/2013
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
06/2014 - 07/2013
1cilgavimabIBA
04/2024
1tixagevimabIBA
04/2024
1cilgavimab and tixagevimab drug combinationIBA
04/2024
1COVID-19 VaccinesIBA
04/2024
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2024
1PhytochemicalsIBA
12/2023
1AdipokinesIBA
10/2023
1Interleukin-6 (Interleukin 6)IBA
10/2023
1VimentinIBA
10/2023
1Conditioned Culture MediaIBA
10/2023
1Immune Checkpoint ProteinsIBA
01/2023
1Vehicle Emissions (Emissions, Vehicle)IBA
01/2023
1Neuroprotective AgentsIBA
01/2023
1Angiotensin Receptor AntagonistsIBA
01/2023
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
09/2022
1Blood Glucose (Blood Sugar)IBA
01/2022
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2022
1DA-1241IBA
01/2022
1Polysaccharides (Glycans)IBA
06/2021
1VaccinesIBA
06/2021
1Indicators and Reagents (Reagents)IBA
10/2020
1CholesterolIBA
08/2020
1LDL CholesterolIBA
08/2020
1HematinicsIBA
01/2020
1HepcidinsIBA
01/2020
1IronIBA
01/2020
1ferric carboxymaltoseIBA
01/2020
1Hemoglobins (Hemoglobin)IBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
12/2019
1LC15-0444IBA
12/2019
11- (1- (imidazo(1,2- a)pyridin- 6- yl)ethyl)- 6- (1- methyl- 1H- pyrazol- 4- yl)- 1H- (1,2,3)triazolo(4,5- b)pyrazineIBA
10/2019
1atezolizumabIBA
10/2019
1Simvastatin (Zocor)FDA LinkGeneric
07/2019
1XELOXIBA
07/2019
1Bevacizumab (Avastin)FDA Link
07/2019
1Vitamin DFDA LinkGeneric
05/2019
1AndrogensIBA
05/2019

Therapy/Procedure

10Drug Therapy (Chemotherapy)
04/2024 - 01/2017
6Therapeutics
04/2024 - 01/2019
2Cell Transplantation
04/2023 - 09/2022
2Dietary Approaches To Stop Hypertension
01/2023 - 01/2021
2Adjuvant Chemoradiotherapy
12/2018 - 06/2016
1Intramuscular Injections
04/2024
1Hematopoietic Stem Cell Transplantation
09/2023
1Liver Transplantation
01/2023
1Salvage Therapy
10/2019